Dose-response study of alendronate sodium for the treatment of cancer-associated hypercalcemia.

199354 citationsJournal Article

Authors

S R Nussbaum · Harvard University

Raymond P. Warrell

Abstract

While a statistically significant dose-response relationship was not clearly evident at doses greater than 5 mg, single doses of > or = 5 mg alendronate sodium effectively lowered serum calcium concentrations and were well tolerated in the treatment of cancer-associated hypercalcemia.

Topics & Keywords

Bone health and treatments Bone and Joint Diseases Medical Imaging and Pathology Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 11, Issue 8, pp. 1618-1623

DOI: 10.1200/jco.1993.11.8.1618

Field-Weighted Citation Impact: 2.14